University of Maryland, Baltimore Celebrates Growing Class of Palliative Care Graduates
August 20, 2026
Class of 2026 brings together health professionals from across disciplines and around the world, including the program’s sixth PhD graduates
August 20, 2026
Class of 2026 brings together health professionals from across disciplines and around the world, including the program’s sixth PhD graduates
August 18, 2026
Recipients will develop innovative ideas into practical solutions that improve patient care through the School’s pharmapreneurship initiative.
August 14, 2026
New “3+4” agreement creates a streamlined, seven-year pathway for Frostburg State University students to earn bachelor’s and Doctor of Pharmacy degrees while expanding opportunities to meet Maryland’s pharmacy workforce needs.
August 11, 2026
Founded in 1841, the School of Pharmacy helped turn a trade into a profession, shaped pharmacy education and practice in Maryland, and has extended its impact to the nation and the world.
August 6, 2026
Assistant professor recognized for innovation, leadership, and service to the pharmacy profession.
August 3, 2026
2023 wildfire smoke cost Maryland more than $2 million in health care and productivity costs. Research shows what steps could be taken to reduce future impact.
July 28, 2026
The Experiential Learning Program’s new Student Support Fund opens doors for student pharmacists.
July 24, 2026
Susan dosReis will help guide ISPE’s strategic priorities and advance global efforts in drug safety, effectiveness, and population health research.
July 21, 2026
Clinical affiliate faculty serve as preceptors and earn academic advancement through teaching, scholarship, and service.
December 11, 2024
C. Daniel Mullins, PhD, honored with Avedis Donabedian Outcomes Research Award for 30-year career focused on improving health outcomes.
December 9, 2024
The School of Pharmacy’s director of human resources is honored for her hard work, dedication, innovation, and ability to mix excellence with empathy.
December 3, 2024
Andrew Coop, PhD, a medicinal chemist with expertise in the pharmacology of psychedelics, will lead an effort to explore pathways for the safe, accessible, and equitable use of natural psychedelics.